Effect of Ribavirin, in Combination With Interferon in Patients With Hepatitis C, on the Bleeding Risk Associated With Selective Serotonin Reuptake Inhibitors
J Clin Psychiatry 2008;69(4):679-680 [letter]
© Copyright 2016 Physicians Postgraduate Press, Inc.
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
We read with great interest the recent article by Martin
reporting that the bleeding risk associated with use of selective
serotonin reuptake inhibitors (SSRIs) during antiviral
therapy for chronic hepatitis C (CHC) is lower than that previously
Several reports had revealed the increasing risk
of bleeding, including retinal hemorrhages or gastrointestinal
bleeding, by administrating SSRIs to patients receiving interferon-
Ribavirin was used in combination with interferon in the
treatment of patients with CHC in the study by Martin et al.1